{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-047017","form_type":"8-K","ticker":"CELU","cik":"0001752828","company_name":"Celularity Inc","filed_at":"2023-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.112764+00:00","generated_at":"2026-06-10T22:55:59.372726+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Celularity appoints Dr. Geoffrey Ling to board; Dr. von Eschenbach resigns","bullets":["Dr. Andrew von Eschenbach resigned as Class I director effective August 31, 2023, not due to any disagreement.","Dr. Geoffrey Shiu Fei Ling appointed as Class I director to fill the vacancy, effective August 31, 2023.","Dr. Ling received a stock option for 1,250,000 shares at $0.324 exercise price, vesting over three years.","Dr. Ling brings >30 years experience in pharma, academia, DARPA, and military; retired U.S. Army colonel."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-047017","json":"https://secwatch.observer/filing/0000950170-23-047017.json","markdown":"https://secwatch.observer/filing/0000950170-23-047017.md","text":"https://secwatch.observer/filing/0000950170-23-047017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1752828/000095017023047017/0000950170-23-047017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1752828/000095017023047017/celu-20230831.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:55:59.372726+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9038f0df4c","claim":"Geoffrey Shiu Fei Ling was appointed as Class I Director at Celularity Inc.","evidence_excerpt":"the board appointed Geoffrey Shiu Fei Ling, M.D., as a Class I director to fill the vacancy left by the resignation of Dr. von Eschenbach, to serve until his successor is elected and qualified","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000095017023047017/0000950170-23-047017-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"},{"claim_id":"c348b0711f","claim":"Andrew C. von Eschenbach resigned as Class I Director at Celularity Inc.","evidence_excerpt":"Andrew C. von Eschenbach, M.D., a Class I member of the board of directors of Celularity Inc., or Celularity, notified the board of directors of his intention to resign as a member of the board and all committees thereof effective August 31, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000095017023047017/0000950170-23-047017-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}